CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
EMBr Wave +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05086705
NCT05086705N/ACompleted
CompareCT.gov

Cool Down With EMBr: Enhancing Menopausal Hot Flash Symptom Reduction After Breast Cancer

Ohio State University Comprehensive Cancer Center·interventional·Posted Oct 21, 2021·Updated Apr 22, 2025

In Brief

A clinical study evaluating EMBr Wave and Questionnaire Administration for Breast Carcinoma and 3 related conditions. Completed, enrolled 50 participants across 1 site.

Detailed Summary

This trial studies how well EMBr Wave technology works in reducing hot flashes in women with a history of breast cancer. Hot flashes are a common symptom experienced by menopausal women. The standard treatment for hot flashes is hormone replacement therapy, however hormone replacement therapy cannot be used in women with a history of, or active, breast cancer. EMBr Wave is a personal heating and cooling device worn on the wrist. EMBr Wave may help reduce hot flash severity in women with a history of breast cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Carcinoma, Breast Ductal Carcinoma In Situ, Breast Lobular Carcinoma In Situ, Hot Flashes
CountriesUnited States
CollaboratorsEmbr Labs, Inc.

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedOct 21, 2021
Enrollment StartOct 7, 2020
Primary CompletionAug 24, 2023
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 4.7 years ago

Interventions

EMBr Wavedevice

Use EMBr Wave

Questionnaire Administrationother

Ancillary studies